Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy

Virology

Volumn 389, Issue 1-2, 2009, Pages 100-107

  Brandsma, Janet L ^a,b   Sun, Ying ^a   Lizardi, Paul M ^a,b   Tuck, David P ^a,b   Zelterman, Daniel ^a,b   Haines III, G Kenneth ^a   Martel, Maritza ^a   Harigopal, Malini ^a   Schofield, Kevin ^a   Neapolitano, Matthew ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

Biomarker; Bisulfite sequencing; Cervical cancer; Cervical cancer screening; DNA methylation; Gene expression regulation, viral; Genome, viral; Human papillomavirus 16; Uterine cervical neoplasia

Indexed keywords

BIOLOGICAL MARKER; BISULFITE; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOLOGY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE MAPPING; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX; UTERINE CERVIX CANCER; VIRUS GENOME; VIRUS IDENTIFICATION;

BIOLOGICAL MARKERS; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 67349204495     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.03.029     Document Type: Article

References (31)

1. Alazawi W., Pett M., Arch B., Scott L., Freeman T., Stanley M.A., and Coleman N. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res. 62 23 (2002) 6959-6965
2. Badal V., Chuang L.S.H., Tan E.H.-H., Badal S., Villa L.L., Wheeler C.M., Li B.F.L., and Bernard H.-U. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol. 77 11 (2003) 6227-6234
3. Badal S., Badal V., Calleja-Macias I.E., Kalantari M., Chuang L.S.H., Li B.F.L., and Bernard H.-U. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324 2 (2004) 483-492
4. Balderas-Loaeza A., Anaya-Saavedra G., Ramirez-Amador V.A., Guido-Jimenez M.C., Kalantari M., Calleja-Macias I.E., Bernard H.-U., and Garcia-Carranca A. Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int. J. Cancer 120 10 (2007) 2165-2169
5. Ballestar E., and Esteller M. Epigenetic gene regulation in cancer. Adv. Genet. 61 (2008) 247-267
6. Bernstein B.E., Meissner A., and Lander E.S. The mammalian epigenome. Cell 128 4 (2007) 669-681
7. DeFilippis R., Goodwin E., Wu L., and DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 77 2 (2003) 1551-1563
8. DiMaio D., and Miller G. Thirty years into the genomics era: tumor viruses led the way. Yale J. Biol. Med. 79 3-4 (2006) 179-185
9. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., and Markowitz L.E. Prevalence of HPV infection among females in the United States.[see comment]. JAMA 297 8 (2007) 813-819
10. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21 35 (2002) 5427-5440
11. Flores E.R., Allen-Hoffmann B.L., Lee D., Sattler C.A., and Lambert P.F. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology 262 2 (1999) 344-354
12. Goldhaber-Fiebert J.D., Stout N.K., Salomon J.A., Kuntz K.M., and Goldie S.J. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.[see comment]. J. Natl. Cancer Inst. 100 5 (2008) 308-320
13. Kalantari M., Calleja-Macias I.E., Tewari D., Hagmar B., Lie K., Barrera-Saldana H.A., Wiley D.J., and Bernard H.-U. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J. Virol. 78 23 (2004) 12762-12772
14. Kalantari M., Lee D., Calleja-Macias I.E., Lambert P.F., and Bernard H.-U. Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 374 2 (2008) 292-303
15. Kalantari M., Villa L.L., Calleja-Macias I.E., and Bernard H.-U. Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int. J. Cancer 123 8 (2008) 1832-1840
16. Kim K., Garner-Hamrick P.A., Fisher C., Lee D., and Lambert P.F. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol. 77 23 (2003) 12450-12459
17. Kiviat N.B., Hawes S.E., and Feng Q. Screening for cervical cancer in the era of the HPV vaccine-the urgent need for both new screening guidelines and new biomarkers.[comment]. J. Natl. Cancer Inst. 100 5 (2008) 290-291
18. Li L.-C., and Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18 11 (2002) 1427-1431
19. Paradisi A., Pasquariello N., Barcaroli D., and Maccarrone M. Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J. Biol. Chem. 283 10 (2008) 6005-6012
20. Schiffman M., Herrero R., Desalle R., Hildesheim A., Wacholder S., Rodriguez A.C., Bratti M.C., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Wright T.C., Solomon D., Chen Z., Schussler J., Castle P.E., and Burk R.D. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337 1 (2005) 76-84
21. Spitzer M. In vitro conventional cytology historical strengths and current limitations. Obstet. Gynecol. Clin. North Am. 29 4 (2002) 673-683
22. Suzuki R., and Shimodaira H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22 12 (2006) 1540-1542
23. Team R.D.C. R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria (2007)
24. Trottier H., Mahmud S., Costa M.C., Sobrinho J.P., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., and Franco E.L. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomark. Prev. 15 7 (2006) 1274-1280
25. Turan T., Kalantari M., Calleja-Macias I.E., Cubie H.A., Cuschieri K., Villa L.L., Skomedal H., Barrera-Saldana H.A., and Bernard H.-U. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?. Virology 349 1 (2006) 175-183
26. Turan T., Kalantari M., Cuschieri K., Cubie H.A., Skomedal H., and Bernard H.-U. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 361 1 (2007) 185-193
27. Vinokurova S., Wentzensen N., Kraus I., Klaes R., Driesch C., Melsheimer P., Kisseljov F., Durst M., Schneider A., and von Knebel Doeberitz M. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 68 1 (2008) 307-313
28. Wettstein F.O., and Stevens J.G. Shope papilloma virus DNA is extensively methylated in non-virus-producing neoplasms. Virology 126 2 (1983) 493-504
29. Wiley D.J., Huh J., Rao J.Y., Chang C., Goetz M., Poulter M., Masongsong E., Chang C.I., and Bernard H.-U. Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. J. Acquir. Immune Defic. Syndr.: JAIDS 39 2 (2005) 143-151
30. Zheng Z.-M., and Baker C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 11 (2006) 2286-2302
31. zur Hausen H. Viruses in human cancers. Science 254 5035 (1991) 1167-1173